<DOC>
	<DOC>NCT02521883</DOC>
	<brief_summary>The aim is to investigate the safety and effectiveness of transcranial Direct Current Stimulation (tDCS) in patients with moderate to severe major depression compared to patients treated with conventional therapy. The tDCS will be used as add-on to conventional therapy. This is a randomized 2-arm parallel, double blind study comparing 2 groups of 60 patients.</brief_summary>
	<brief_title>Transcranial Direct Current Stimulation (tDCS) as an add-on Therapy for Treatment of Major Depressive Disorder. (DEPTDCS2014)</brief_title>
	<detailed_description />
	<criteria>Fulfils the ICD10 diagnostic criteria for moderate or severe major depressive episode (F32), or recurrent major depressive episode (F33) Able to understand the purpose and potential risks of the study Able to sign informed consent intracranial metal implants or other foreign intracranial metal object history of neurological conditions e.g. epilepsy, stroke (ischemic or haemorrhagic); brain tumor; increased intracranial pressure etc. schizophrenia bipolar disorder psychotic disorder substance abuse or dependency contraindications to tDCS personality disorder that may prevent him/her to commit to the study skin lesion in the area of stimulation planned treatment of current depressive episode with ECT or rTMS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>